Product Surveillance, Postmarketing

"Product Surveillance, Postmarketing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.

Descriptor ID	D011358
MeSH Number(s)	E05.337.800
Concept/Terms	Product Surveillance, Postmarketing Product Surveillance, Postmarketing Product Surveillance, Post-Marketing Post-Marketing Product Surveillance Post-Marketing Product Surveillances Product Surveillance, Post Marketing Product Surveillances, Post-Marketing Surveillance, Post-Marketing Product Surveillances, Post-Marketing Product Evaluation Studies, Postmarketing Evaluation Study, Postmarketing Postmarketing Evaluation Studies Postmarketing Evaluation Study Studies, Postmarketing Evaluation Study, Postmarketing Evaluation Postmarketing Product Surveillance Postmarketing Product Surveillances Product Surveillances, Postmarketing Surveillance, Postmarketing Product Surveillances, Postmarketing Product Drug Surveillance, Postmarketing Drug Surveillance, Postmarketing Drug Surveillances, Postmarketing Postmarketing Drug Surveillance Postmarketing Drug Surveillances Surveillance, Postmarketing Drug Surveillances, Postmarketing Drug

Below are MeSH descriptors whose meaning is more general than "Product Surveillance, Postmarketing".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Evaluation Studies as Topic [E05.337]
Product Surveillance, Postmarketing [E05.337.800]

Below are MeSH descriptors whose meaning is related to "Product Surveillance, Postmarketing".

Below are MeSH descriptors whose meaning is more specific than "Product Surveillance, Postmarketing".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Product Surveillance, Postmarketing" by people in this website by year, and whether "Product Surveillance, Postmarketing" was a major or minor topic of these publications.

Bar chart showing 31 publications over 17 distinct years, with a maximum of 4 publications in 2011 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2000	0	2	2
2001	1	0	1
2004	0	1	1
2005	1	0	1
2007	2	0	2
2008	1	0	1
2010	2	1	3
2011	2	2	4
2014	1	2	3
2015	0	1	1
2016	0	1	1
2017	1	1	2
2019	1	0	1
2020	2	2	4
2021	1	1	2
2024	0	1	1

Below are the most recent publications written about "Product Surveillance, Postmarketing" by people in Profiles.

Moroco AE, Wei Z, Byrd I, Rasmussen A, Chio EG, Soose RJ, Huyett P, Steffen A, Heiser C, Boon MS, Huntley CT. Device-related outcomes following hypoglossal nerve stimulator implantation. J Clin Sleep Med. 2024 Sep 01; 20(9):1497-1503.

View in: PubMed
Dodick DW, Tepper SJ, Ailani J, Pannacciulli N, Navetta MS, Loop B, Zhang F, Khodavirdi AC, Mann A, Abdrabboh A, Kalim J. Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data. Headache. 2021 10; 61(9):1411-1420.

View in: PubMed
Chiang CC, Arca KN, Dunn RB, Girardo ME, Quillen JK, Dodick DW, Starling AJ. Real-world efficacy, tolerability, and safety of ubrogepant. Headache. 2021 Apr; 61(4):620-627.

View in: PubMed
Semmo N, M?llhaupt B, Ruckstuhl L, Magenta L, Clerc O, Torgler R, Semela D. A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment na?ve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study. PLoS One. 2020; 15(11):e0241267.

View in: PubMed
Hull J, Deitrick J, Groome K. Maturation for Hemodialysis in the Ellipsys Post-Market Registry. J Vasc Interv Radiol. 2020 Sep; 31(9):1373-1381.

View in: PubMed
Hale PM, Ali AK, Buse JB, McCullen MK, Ross DS, Sabol ME, Tuttle RM, Stemhagen A. Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry. Thyroid. 2020 10; 30(10):1397-1398.

View in: PubMed
Shi W, Blumenthal DT, Oberheim Bush NA, Kebir S, Lukas RV, Muragaki Y, Zhu JJ, Glas M. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice. J Neurooncol. 2020 Jul; 148(3):489-500.

View in: PubMed
Heiser C, Steffen A, Boon M, Hofauer B, Doghramji K, Maurer JT, Sommer JU, Soose R, Strollo PJ, Schwab R, Thaler E, Withrow K, Kominsky A, Larsen C, Kezirian EJ, Hsia J, Chia S, Harwick J, Strohl K, Mehra R. Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry. Eur Respir J. 2019 01; 53(1).

View in: PubMed
Gray WA, Garcia LA, Amin A, Shammas NW. Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry. Cardiovasc Revasc Med. 2018 07; 19(5 Pt A):506-511.

View in: PubMed
Gopal AD, Rathi VK, Teng CC, Del Priore L, Ross JS. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015. Ophthalmology. 2017 08; 124(8):1237-1246.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement